Schonfeld Strategic Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-359,267
| Closed | -$5.65M | – | 2430 |
|
|
2024
Q1 | $5.65M | Buy |
359,267
+79,756
| +29% | +$1.25M | 0.04% | 505 |
|
|
2023
Q4 | $4.51M | Buy |
279,511
+46,611
| +20% | +$752K | 0.03% | 492 |
|
|
2023
Q3 | $2.96M | Buy |
232,900
+5,947
| +3% | +$75.6K | 0.02% | 604 |
|
|
2023
Q2 | $3.2M | Sell |
226,953
-20,285
| -8% | -$286K | 0.03% | 616 |
|
|
2023
Q1 | $3.82M | Buy |
247,238
+53,472
| +28% | +$826K | 0.04% | 508 |
|
|
2022
Q4 | $3.18M | Buy |
193,766
+22,629
| +13% | +$371K | 0.03% | 644 |
|
|
2022
Q3 | $3.17M | Buy |
+171,137
| New | +$3.17M | 0.03% | 693 |
|
|
2022
Q1 | – | Sell |
-14,900
| Closed | -$145K | – | 2809 |
|
|
2021
Q4 | $145K | Sell |
14,900
-79,940
| -84% | -$778K | ﹤0.01% | 1751 |
|
|
2021
Q3 | $3.22M | Buy |
94,840
+56,369
| +147% | +$1.92M | 0.03% | 506 |
|
|
2021
Q2 | $1.41M | Buy |
38,471
+11,375
| +42% | +$417K | 0.02% | 796 |
|
|
2021
Q1 | $1.22M | Sell |
27,096
-4,727
| -15% | -$212K | 0.01% | 788 |
|
|
2020
Q4 | $1.82M | Sell |
31,823
-1,077
| -3% | -$61.5K | 0.02% | 591 |
|
|
2020
Q3 | $1.69M | Buy |
32,900
+12,241
| +59% | +$628K | 0.03% | 523 |
|
|
2020
Q2 | $1.23M | Buy |
+20,659
| New | +$1.23M | 0.03% | 515 |
|
|
2020
Q1 | – | Sell |
-29,371
| Closed | -$1.83M | – | 1590 |
|
|
2019
Q4 | $1.83M | Buy |
+29,371
| New | +$1.83M | 0.04% | 353 |
|
|
2018
Q2 | – | Sell |
-30,146
| Closed | -$604K | – | 1004 |
|
|
2018
Q1 | $604K | Buy |
30,146
+15,146
| +101% | +$303K | 0.05% | 434 |
|
|
2017
Q4 | $340K | Sell |
15,000
-35,000
| -70% | -$793K | 0.03% | 549 |
|
|
2017
Q3 | $950K | Buy |
+50,000
| New | +$950K | 0.09% | 276 |
|